Formato de listado
Cambio de listado
Listar por Categoría
Regresar
Notification
CMS Announces Release of the State RFA for the CGT Access Model
- [Registrante]Centers for Medicare & Medicaid Services (CMS)
- [Idioma]日本語
- [Área]Baltimore, MD
- Fecha registrada : 2024/06/28
- Fecha de Publicación : 2024/06/28
- Fecha de cambio : 2024/06/28
- Vista de Página. :
- "Guía de Ciudad" para encontrar Tiendas
-
- Washington, DC ・ Virginia ・ Maryland ・ C...
-
Para quienes han dejado Japón y viven en EE.UU., lo más preocupante e importante es su salud y la de sus familias. Situada en Nueva Jersey, nuestra clínica ofrece una gama completa de servicios médico...
+1 (201) 581-8553ひばりファミリーメディカル
-
- Psiquiatría ・ Bienvenido a la oficina de...
-
Muchos de ellos están expuestos a una serie de tensiones, como la falta de familiaridad con un país extranjero, la inadaptación a un nuevo trabajo o escuela, las barreras culturales y lingüísticas y l...
+1 (201) 809-3508精神科・心療内科医 松木隆志
-
- Es una organización sin ánimo de lucro q...
-
FLAT ・ FLAT es una organización sin ánimo de lucro con sede en Nueva York y que opera en todo EE.UU., poniendo en contacto a profesionales sanitarios y pacientes de habla japonesa y apoyando a la comu...
+1 (772) 349-9459FLAT ・ふらっと
-
- Ahora aceptando nuevos estudiantes ! ・ T...
-
SAPIX clases están disponibles en los EE.UU. ! Y ! SAPIX EE.UU. clases, que son diferentes de SAPIX en Japón, están disponibles en el Gran Washington DC ! Entrar en Japón ・ Examen. ¡Entonces déjelo...
+1 (914) 358-5337SAPIX USA
CMS Announces Release of the State RFA for the CGT Access Model
Today, the Centers for Medicare & Medicaid Services (CMS) announced the release of the State Request for Applications (RFA) for the Cell and Gene Therapy (CGT) Access Model, announced in January 2024, which will initially focus on gene therapies for sickle cell disease [ https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.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.7MsGQnSvQhNFyi2TQN6WnnPcnGI7ishxhqc2oJyP-bg/s/1113586784/br/244946024629-l ]. The CGT Access Model aims to improve the lives of people with Medicaid living with rare and severe diseases by increasing their access to potentially life-changing treatments. The model will test whether a CMS-led approach to developing and administering outcomes-based agreements (OBAs) for cell and gene therapies improves Medicaid beneficiaries’ health outcomes, broadens access to innovative treatment, and reduces health care expenditures.
The State RFA [ https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDEsInVyaSI6ImJwMjpjbGljayIsInVybCI6Imh0dHBzOi8vd3d3LmNtcy5nb3YvZmlsZXMvZG9jdW1lbnQvY2d0LW1vZGVsLXJmYS5wZGYiLCJidWxsZXRpbl9pZCI6IjIwMjQwNjI4Ljk2ODk0OTUxIn0.BEbVsSqMWZNLeJfH1321JXKjOfa6prdKQ9LPOvr8J-o/s/1113586784/br/244946024629-l ] is available on the model webpage [ https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.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.lTbcAGPD1o-sJzc8_6SdQhbjZVD2V8ytsBc8arqHSL8/s/1113586784/br/244946024629-l ] and is open to all states, the District of Columbia, and all U.S. territories participating in the Medicaid Drug Rebate Program. Participation in the Cell and Gene Therapy (CGT) Access Model will be voluntary for both manufacturers and states. States may submit applications to participate in the model after the negotiated Key Terms are communicated to all states in December 2024. The application portal will be open from December 2024 to February 28, 2025. View the State RFA factsheet [ https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDMsInVyaSI6ImJwMjpjbGljayIsInVybCI6Imh0dHBzOi8vd3d3LmNtcy5nb3YvZmlsZXMvZG9jdW1lbnQvY2d0LW1vZGVsLXJmYS1mYWN0LXNoZWV0LnBkZiIsImJ1bGxldGluX2lkIjoiMjAyNDA2MjguOTY4OTQ5NTEifQ.e9MXdV5jiP1Ie6V6NugvjB8GmX5wDzdhR8hvR7fH54I/s/1113586784/br/244946024629-l ] for additional details.
More information about the model can be found on the model webpage [ https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.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.K0sjUQe2K6fhv8WNhm0Tex8zgow4-xw_jNUPAQUQtfk/s/1113586784/br/244946024629-l ] and in the CGT Access Model press release [ https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.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.1tw6VLAqxVh5tNnGT_k73-r9siLTpuKcbcq-tAfsySM/s/1113586784/br/244946024629-l ]. For updates on the model, please register for the model listserv [ https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.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.L9E3IaGMG4T9Yk-PHIYqHPs5loS3GY4F0-Pxac1hhic/s/1113586784/br/244946024629-l ].
Questions about the model can be submitted to CGTModel@cms.hhs.gov [ https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDcsInVyaSI6ImJwMjpjbGljayIsInVybCI6Imh0dHBzOi8vbG5rcy5nZC9sL2V5SmhiR2NpT2lKSVV6STFOaUo5LmV5SmlkV3hzWlhScGJsOXNhVzVyWDJsa0lqb3hNRFlzSW5WeWFTSTZJbUp3TWpwamJHbGpheUlzSW5WeWJDSTZJbWgwZEhBNkx5OXNhVzVyTG1WdFlXbHNMbVI1Ym1WamRDNXVaWFF2YkdsdWF5NXdhSEFpTENKaWRXeHNaWFJwYmw5cFpDSTZJakl3TWpRd016QTNMamt4TkRJek1ETXhJbjAudW1HendZdUVPWVFGYm9EbkFKT3FvUVhOZHBXSUlfQVptVnlidDFPZkVmQS9zLzExMTM1ODY3ODQvYnIvMjM4Mzc3MjE0NjY2LWwiLCJidWxsZXRpbl9pZCI6IjIwMjQwNjI4Ljk2ODk0OTUxIn0.SMWoKaIrkb39OZL5TbWVJ_RM1YkPW6IJIvxRvvPqlKs/s/1113586784/br/244946024629-l ].
Follow us on X (formerly Twitter [ https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDgsInVyaSI6ImJwMjpjbGljayIsInVybCI6Imh0dHBzOi8vdHdpdHRlci5jb20vQ01TaW5ub3ZhdGVzIiwiYnVsbGV0aW5faWQiOiIyMDI0MDYyOC45Njg5NDk1MSJ9.0Vji7sKTtp4oeMVJMdgUf8me5cn6FXJid6iiXJYhSgo/s/1113586784/br/244946024629-l ]) | Visit the CMS Innovation Center website [ https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDksInVyaSI6ImJwMjpjbGljayIsInVybCI6Imh0dHBzOi8vd3d3LmNtcy5nb3YvcHJpb3JpdGllcy9pbm5vdmF0aW9uL292ZXJ2aWV3IiwiYnVsbGV0aW5faWQiOiIyMDI0MDYyOC45Njg5NDk1MSJ9.zQoInqN19UNQtymPU30o_3-_CCyta5eMzJKalic7nPk/s/1113586784/br/244946024629-l ]
*CMS Office of Minority Health* | Working to Achieve Health Equity
"Paid for by the US Department of Health and Human Services"
________________________________________________________________________
You're getting this message because you subscribed to get email updates from the Centers for Medicare & Medicaid Services (CMS) [ http://www.cms.gov/ ].
Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page [ https://public.govdelivery.com/accounts/USCMS/subscriber/edit?preferences=true#tab1 ]. You will need to use your email address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com [ https://subscriberhelp.govdelivery.com/ ].
This service is provided to you at no charge by Centers for Medicare & Medicaid Services (CMS) [ http://www.cms.gov ].
________________________________________________________________________
This email was sent to mshinji3056@gmail.com using GovDelivery Communications Cloud 7500 Security Boulevard · Baltimore MD 21244
body .abe-column-block {min-height: 5px;}